Summary & Overview
HCPCS Level II C1878: Vocal Cord Medialization Implantable Synthetic
HCPCS Level II code C1878 denotes synthetic implantable material used for vocal cord medialization, a surgical intervention to improve glottic closure and voice outcomes in patients with unilateral vocal fold paresis or paralysis. Nationally, this code matters because it captures a discrete, device-oriented supply used in otolaryngology procedures and factors into device procurement, surgical supply billing, and payer coverage policies.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of billing context for C1878, including typical sites of service and clinical purpose, expected reporting practices, and common modifiers used with device and implantable supply codes. The publication also outlines benchmarks for utilization and reimbursement where available, highlights policy considerations that affect payer coverage and coding consistency, and situates the code within clinical pathways for vocal cord medialization.
The content is intended for clinicians, coding professionals, and policy analysts seeking clear, national-level context on how HCPCS Level II code C1878 is deployed in surgical practice and payer interactions. Data not available in the input will be noted explicitly in relevant sections.
Billing Code Overview
HCPCS Level II code C1878 describes material for vocal cord medialization, synthetic (implantable). This code represents an implantable synthetic material used during surgical procedures to medialize the vocal fold, typically to improve glottic closure and voice function in patients with vocal cord paralysis or paresis.
Service type: Implantable surgical implant for vocal cord medialization.
Typical site of service: Ambulatory surgery center or hospital operating room for otolaryngology or head and neck surgical procedures.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult who presents with progressive hoarseness, breathy voice, or aspiration related to unilateral vocal fold paralysis or paresis. The otolaryngology team evaluates the patient with laryngoscopy and stroboscopy to confirm glottic insufficiency from medialization deficiency. Conservative measures (voice therapy, injection augmentation) have failed or are insufficient, and the patient elects permanent medialization using an implantable synthetic material coded as C1878. The workflow includes preoperative assessment (history, voice assessment, imaging as needed), informed consent documenting risks/benefits, scheduling of direct laryngoscopy with local or general anesthesia, placement of the synthetic implant for vocal cord medialization (often via thyroid cartilage window or endoscopic approach), intraoperative voice assessment when feasible, post-anesthesia recovery, and outpatient follow-up for voice outcomes and wound/airway checks. Typical sites of service are the operating room, ambulatory surgery center, or hospital outpatient department. Common payors include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare for coverage and claims processing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When work or complexity significantly exceeds typical for the procedure |